NATIONAL INSTITUTES OF HEALTH has floated a tender for Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03). The project location is USA and the tender is closing on 21 Feb 2022. The tender notice number is PAR-19-257, while the TOT Ref Number is 32383930. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)

Deadline : 21 Feb 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 32383930

Document Ref. No. : PAR-19-257

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
USA
Email :FBOWebmaster@OD.NIH.GOV

Tender Details

Tender are invited for Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)

CFDA Number : 93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research

Cost Sharing or Matching Requirement : No

Closing Date for Applications: Feb 21, 2022

Posted Date : Apr 17, 2019

Description: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) announces a program that provides NIAMS-supported K08 and K23 recipients the opportunity to apply for Small Grant (R03) support at some point during the second to fourth year of their K award. Through this FOA, the NIAMS is seeking to enhance the capability of its clinical scientists to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that provide preliminary data to support a subsequent R01, or equivalent, application. Clinical trials of any phase will not be supported by this FOA.

Documents

 Tender Notice